Oklahoma-based Cytovance Biologics and California-based Celltheon have partnered to deliver an improved, integrated solution that combines Celltheon’s CHO-K1-based cell line development platform and Cytovance’s fully integrated CDMO services. The goal of the collaboration is to better support the rising demand for development and manufacturing of more complex biologics, particularly in US-based facilities. “We have seen firsthand the improved timelines, manufacturability, and product yie...